Literatur
- 1
Regitz-Zagrosek V.
Therapeutic implications of the gender-specific aspects of cardiovascular disease.
Nat Rev Drug Discov.
2006;
5
425-439
- 2
Lowel H, Meisinger C, Heier M, Hormann A, Kuch B, Gostomzyk J, Koenig W.
Sex specific trends of sudden cardiac death and acute myocardial infarction: results
of the population-based KORA/MONICA-Augsburg register 1985 to 1998.
Dtsch Med Wochenschr.
2002;
127
2311-2316
- 3
Regitz-Zagrosek V, Lehmkuhl E, Lehmkuhl H B, Hetzer R.
Gender aspects in heart failure. Pathophysiology and medical therapy.
Arch Mal Coeur Vaiss.
2004;
97
899-908
- 4
Mieres J H, Shaw L J, Arai A. et al .
Role of noninvasive testing in the clinical evaluation of women with suspected coronary
artery disease: consensus statement from the Cardiac Imaging Committee, Council on
Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council
on Cardiovascular Radiology and Intervention, American Heart Association.
Circulation.
2005;
111
682-696
- 5
Redberg R F, Cannon R O 3rd, Bairey M erz, Lerman A, Reis S E, Sheps D S.
Women’s Ischemic Syndrome Evaluation: current status and future research directions:
report of the National Heart, Lung and Blood Institute workshop: October 2 - 4, 2002:
Section 2: stable ischemia: pathophysiology and gender differences.
Circulation.
2004;
109
e47-49
- 6
Vaccarino V, Parsons L, Every N R, Barron H V, Krumholz H M.
Sex-based differences in early mortality after myocardial infarction. National Registry
of Myocardial Infarction 2 Participants.
N Engl J Med.
1999;
341
217-225
- 7
Antoniucci D, Valenti R, Moschi G. et al .
Sex-based differences in clinical and angiographic outcomes after primary angioplasty
or stenting for acute myocardial infarction.
Am J Cardiol.
2001;
87
289-293
- 8
Vaccarino V, Abramson J L, Veledar E, Weintraub W S.
Sex differences in hospital mortality after coronary artery bypass surgery: evidence
for a higher mortality in younger women.
Circulation.
2002;
105
1176-1181
- 9
Regitz-Zagrosek V, Lehmkuhl E, Hocher B. et al .
Gender as a risk factor in young, not in old, women undergoing coronary artery bypass
grafting.
J Am Coll Cardiol..
2004;
44
2413-2414
- 10
Makkar R R, Fromm B S, Steinman R T, Meissner M D, Lehmann M H.
Female gender as a risk factor for torsades de pointes associated with cardiovascular
drugs.
JAMA.
1993;
270
2590-2597
- 11
Rodriguez I, Kilborn M J, Liu X K, Pezzullo J C, Woosley R L.
Drug-induced QT prolongation in women during the menstrual cycle.
JAMA.
2001;
285
1322-1326
- 12
Theres H, Maier B, Matteucci G othe. et al .
Influence of gender on treatment and short-term mortality of patients with acute myocardial
infarction in Berlin.
Z Kardiol.
2004;
93
954-963
- 13
Yusuf S, Ounpuu S, Dans T, INTERHEART S tudy.
Effect of potentially modifiable risk factors associated with myocardial infarction
in 52 countries (the INTERHEART study): case-control study.
Lancet.
2004;
364
937-952
- 14
Shaw L J, Merz N B, Pepine C J. et al .
for the WISE Investigation. Gender differences in traditional and novel risk factors,
symptom evaluation, and gender-optimized diagnostic strategies.
J Am Coll Cardiol.
2006;
46
4S-20S
- 15
Stramba-Badiale M, Fox K M, Priori S G. et al .
Cardiovascular diseases in women: a statement from the policy conference of the European
society of cardiology.
Eur Heart J.
2006;
27
994-1005
- 16
Tanis B C, van den Bosch M AAJ, Kemmeren J M. et al .
Oral contraceptives and the risk of myocardial infarction.
N Engl J Med.
2001;
345
1787-1793
- 17
Diverse P opulations.
Smoking, body weight, CHD mortality in diverse populations.
Prev Medicine.
2004;
38
834-840
- 18
McLarty A, Mann N, Lawson W, Forster A.
Womens heart health series: a mini-symposium.
Med Sci Monit.
2003;
9
103-110
- 19
Fröhlicher E S, Miller N H, Christopherson D J. et al .
High rates of sustained smoking cessation in women hospitalized with cardiovascular
disease.
Circulation.
2004;
109
587-593
- 20
Manolio T A, Pearson T A, Wenger N K, Barrett-Connor E, Payne G H, Harlan W R.
Cholesterop and heart disease in older persons and women. Review of an NHLBI workshop.
Ann Epidemiol.
1992;
2
161-176
- 21
Hokanson J E, Austin M A.
Plasma triglyceride level is a risk factor for cardiovascular disease independent
of high-density lipoprotein level: a meta-analysis of population based prospective
Studies.
J Cardiovasc Risk.
1996;
3
213-219
- 22
Stessen J A, Ginocchio G, Thijs L, Fagard R.
Conventional and ambulatori blood pressure and menopause in a prospective population
study.
J Hum Hypertens.
1997;
11
507-514
- 23
Mason P J, Manson J E, Sesso H D. et al .
Blood pressure and risk of secondary cardiovascular events in women.
Circulation.
2004;
109
1623-1629
- 24
Steingart R M, Packer M, Hamm P. et al .
Sex differences in the management of coronary artery disease. Survival and Ventricular
Enlargement Investigators.
N Engl J Med.
1991;
325
226-230
- 25
Conroy R M, Pyörälä K, Fitzgerald A P. et al .
on behalf of the SCORE project group. Estimation of ten-year risk of fatatl cardiovascular
disease in Europe: the SCORE project.
Eur Heart J.
2003;
24
987-1003
- 26
Huxley R, Barzi F, Woodward M.
Excess of fatal coronary heart disease associated with diabetes in men and women:
meta-analysis of 37 prospective cohort studies.
BMJ.
2006;
332
73-78
- 27
Weiss R, Dziura J, Burgert T S. et al .
Obesity and the metabolic syndrome in Children and Adolescents.
N Engl J Med.
2004;
350
2362-2374
- 28
Regitz-Zagrozek V, Lehmkuhl E, Weickert M O.
Gender differences in the metabolic syndrome and their role for cardiovascualr disease.
Clin Res Cardiol.
2006;
95
136-147
- 29
Wessel T R, Arant C B, Olson M B. et al .
Relationship of physical fitness vs body mass index with coronary artery disease and
cardiovascular events in women.
JAMA.
2004;
292
1179-1187
- 30
Yusuf S, Hawken S, Ounpuu S. et al .
; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in
27. 000 participants from 52 countries: a case-control study.
Lancet.
2005;
366
1640-1649
- 31
Li T Y, Rana J S, Manson J E. et al .
Obesity as compared with physical activity in predicting risk of coronary artery disease.
Circulation.
2006;
113
499-506
- 32
Ross R.
Atherosclerosis an inflammatory disease.
N Engl J Med.
1999;
340
115-126
- 33
Brezinka V, Kittel F.
Psychosocial factors of coronary heart disease in women: a review.
Social Science and Medicine.
1996;
42
1351-1362
- 34
Bjerkest O, Nordahl H N, Mykletun A, Holmen J, Dahl A A.
Anxiety and depression following myocardial infarction: gender differences in a 5-year
prospective study.
J Psychosom Res.
2005;
58
153-161
- 35
Abogast A, Sechtem U.
Diagnose der koronaren Herzkrankheit bei Frauen.
Dtsch Med Wochenschr.
2003;
128
97-102
- 36
Gibbons R J, Balady G J, Bricker J T. et al .
ACC/AHA 2002 guidelines update for exercise testing: summary article: A report of
the American College of Cardiology/American Heart Association task force on practice
guidelines.
Circulation.
2002;
106
1883-1892
- 37
Mora S, Redberg R F, Cui Y. et al .
Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic
women: a 20-year follow-up of the lipid research clinics prevalence study.
JAMA.
2003;
290
1600-1607
- 38
Kwok Y, Kim C, Grady D, Segal M, Redberg R.
Meta-analysis of exercise testing to detect coronary artery disease in women.
Am J Cardiol.
1999;
83
660-666
- 39
Okin P M.
Elektrocardiography in women. Taking the initiative.
Circulation.
2006;
113
464-466
- 40
Shaw L J, Vasey C, Sawada S, Rimmerman C, Marwick T H.
Impact of gender on risk stratifitcation by exercise and dobutamine stress echocardiography:
long-term mortality in 4234 women and 6898 men.
Eur Heart J.
2005;
26
447-456
- 41
Mieres J H, Shaw L J, Hendel R C. et al .
; Writing Group on Perfusion Imaging in Women. American Society of Nuclear Cardiology
consensus statement: Task Force on Women and Coronary Artery Disease-the role of myocardial
perfusion imaging in the clinical evaluation of coronary artery disease in women.
J Nucl Cardiol.
2003;
10
95-101
- 42
Buchthal S D, den H ollander, Merz C NB. et al .
Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women
with chest pain but normal coronary angiograms.
N Engl J Med.
2000;
342
829-835
- 43
Liao Y, Cooper R S, Mensah G A, McGee D L.
Left ventricular hypertrophy has a greater impact on survival in women than in men.
Circulation.
1995;
92
805-810
- 44
Cleland J G, Swedberg K, Follath F. et al .
The EuroHeart Failure survey programme- a survey on the quality of care among patients
with heart failure in Europe. Part 1: patient characteristics and diagnosis.
Eur Heart J.
2003;
24
442-463
- 45
Mendelsohn M E, Karas R H.
Molecular and cellular basis of cardiovascular gender differences.
Science.
2005;
308
1583-1587
- 46
Nordmeyer J, Eder S, Mahmoodzadeh S. et al .
Upregulation of myocardial estrogen receptors in human aortic stenosis.
Circulation.
2004;
110
3270-3275
- 47
Mahmoodzadeh S, Eder S, Nordmeyer J. et al .
Estrogen receptor alpha up-regulation and redistribution in human heart failure.
Faseb J.
2006;
20
926-934
- 48
Edwards D P.
Regulation of signal transduction pathways by estrogen and progesterone.
Annu Rev Physiol.
2005;
67
335-376
- 49
Dubey R K, Tofovic S P, Jackson E K.
Cardiovascular pharmacology of estradiol metabolites.
J Pharmacol Exp Ther.
2004;
308
403-409
- 50
Sudhir K, Komesaroff P A.
Clinical review 110: Cardiovascular actions of estrogens in men.
J Clin Endocrinol Metab.
1999;
84
3411-3415
- 51
Herrington D M, Howard T D.
ER-alpha variants and the cardiovascular effects of hormone replacement therapy.
Pharmacogenomics.
2003;
4
269-277
- 52
Berry C, Kelly J, Cobbe S M, Eteiba H.
Comparison of femoral bleeding complication after coronary angiography versus percutaneous
coronary intervention.
Am J Cardiol.
2004;
94
361-363
- 53
Rubanyi G M, Kauser K, Johns A.
Role of estrogen receptors in the vascular system.
Vascul Pharmacol.
2002;
38
81-88
- 54
Rathore S S, Wang Y, Krumholz H M.
Sex-based differences in the effect of digoxin for the treatment of heart failure.
N Engl J Med.
2002;
347
1403-1411
- 55
Rathore S S, Curtis J P, Wang Y, Bristow M R, Krumholz H M.
Association of serum digoxin concentration and outcomes in patients with heart failure.
JAMA.
2003;
289
871-878
- 56
Luzier A B, Killian A, Wilton J H, Wilson M F, Forrest A, Kazierad D J.
Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy
volunteers.
Clin Pharmacol Ther.
1999;
66
594-601
- 57
TheMERIT-HFStudyGroup .
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention
Trial in Congestive Heart Failure (MERIT-HF).
Lancet.
1999;
353
2001-2007
- 58
Packer M, Bristow M R, Cohn J N, Colucci W S, Fowler M B, Gilbert E M, Shusterman N H.
The effect of carvedilol on morbidity and mortality in patients with chronic heart
failure. U. S. Carvedilol Heart Failure Study Group.
N Engl J Med.
1996;
334
1349-1355
- 59
Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P.
Sex differences in the prognosis of congestive heart failure: results from the Cardiac
Insufficiency Bisoprolol Study (CIBIS II).
Circulation.
2001;
103
375-380
- 60
CIBISII1999 .
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
Lancet.
1999;
353
9-13
- 61
Wing L M, Reid C M, Ryan P. et al .
A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics
for hypertension in the elderly.
N Engl J Med.
2003;
348
583-592
- 62
Mackay F J, Pearce G L, Mann R D.
Cough and angiotensin II receptor antagonists: cause or confounding?.
Br J Clin Pharmacol.
1999;
47
111-114
- 63
Ridker P M, Cook N R, Lee I M. et al .
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular
disease in women.
N Engl J Med.
2005;
352
1293-1304
- 64
Martin R M, Biswas P N, Freemantle S N, Pearce G L, Mann R D.
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs
in general practice in England: analysis of 48 cohort studies.
Br J Clin Pharmacol.
1998;
46
505-511
- 65
Solomon C G, Hu F B, Dunaif A. et al .
Menstrual cycle irregularity and risk for future cardiovascular disease.
J Clin Endocrinol Metab.
2002;
87
2013-2017
Prof. Dr. Vera Regitz-Zagrosek
Center for Gender in Medicine and Cardiovascular Research Center, Charité and Deutsches
Herzzentrum Berlin (DHZB)
Augustenburger Platz 1
13353 Berlin
Email: vera.regitz-zagrosek@charite.de
